BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Los_Angeles X-WR-TIMEZONE:America/Los_Angeles BEGIN:VEVENT UID:17@intrepidib.com DTSTART;TZID=America/Los_Angeles;VALUE=DATE:20180926 DTEND;TZID=America/Los_Angeles;VALUE=DATE:20180927 DTSTAMP:20220916T051719Z URL:https://intrepidib.com/events/opportunities-and-pitfalls-in-healthcare -ma/ SUMMARY:Opportunities and Pitfalls in Healthcare M&A DESCRIPTION:M&\;A continues to be a driver of change and innovation in t he dynamic healthcare sector for both strategic acquirers looking to accel erate growth and private equity sponsors looking for their next great inve stment.\nIntrepid’s Healthcare Group led a dynamic panel discussion at t he recent ACGLA Business Conference with senior private equity leaders an d corporate executives regarding the opportunities and pitfalls in healthc are M&\;A today. Adam Abramowitz\, Managing Director\, introduced the panel and touched on the current healthcare environment while Jonathan Blu th\, Intrepid’s Head of Healthcare\, moderated the session. Here are som e highlights from the dealmakers and where they might find the next wave o f opportunity.\nImplementing Value-Based Care in the Middle Market\nMore a nd more provider groups are transitioning from fee-for-service to value-ba sed care\, which represents a challenging development for middle-market in vestors to incorporate into their modeling and valuations. It may not be t he ideal strategy for all private equity sponsors to underwrite such a rev enue model change into a valuation case without serious conviction of a su ccessful transition. Migrating to value-based care necessitates robust fin ancial reporting\, sophisticated operations\, and sufficient technology in frastructure to ensure successful\, win-win outcomes. However\, to maximiz e their valuation and options\, panelists felt that all providers should d evelop a strategy on how to address value-based care in their sectors\, re gardless if it remains a small part of their business models today.\nInnov ation Can Provide Many Answers\nPanelists expressed excitement to invest i n and or acquire companies harnessing innovation within healthcare that is driving patient/consumer engagement\, improving care management and enhan cing outcomes. These innovations can increase efficiencies and reduce cost s thereby creating attractive value propositions and M&\;A rationales. Further\, new patient engagement technologies can improve data capture for outcomes analysis as well in niche areas like clinical trial recruitment. Despite their excitement\, some panelists remained hesitant about pushing the innovation envelope too far and believed “tried and true” care mo dels with proven track records of quality care will remain high on buyers ’ wish lists.\nModels That Address Healthcare Spend Will Win\nAmerican h ealthcare spending is broken. Investors and acquirers alike are highly int erested in proven and emerging care models that can significantly reduce s pending while offering great patient experiences and high clinical care. P anelists discussed the importance of addressing all key stakeholders in th e system and how a winning healthcare business provides value to payors\, patients and providers. Solve for the “3Ps\,” and you will be at the t op of everyone’s wish lists.\nContinued Shift Towards Quality\nIn this a ctive and competitive M&\;A market\, panelists discussed how lofty valu ations are pushing them to focus on only the best assets\, both operationa lly and clinically. To justify the premium valuations necessary to win dea ls\, acquirers want comfort when they are partnering with top-tier compani es with strong management teams\, high-quality operations\, and clear path ways for near- and long-term growth.  But\, they also shared that buyers are placing increased scrutiny on outcomes and quality of care. Diligence processes have dramatically increased scrutiny and companies that don’t “check the boxes” may not garner premium valuations and a multitude of transaction options. Preparation is vital—so potential sellers should s trongly consider completing a sell-side ‘Quality of Earnings Report’ a nd\, in some cases\, a coding audit before launching an M&\;A process.\ n\n\nPanelists\n\n Jonathan Gluck\, COO and General Counsel\, Heritage Pr ovider Network\n Anil Asnani\, Senior VP of Corporate Development\, LabCo rp\n David Alpern\, Founding Partner\, Varsity Healthcare Partners\n Sco tt Kauffman\, Principal\, Northlane Capital Partners\n\nEvent Details\nWed nesday\, Sept. 26\, 2018\n\nACGLA Business Conference\n\nBeverly Hilton\n\ n9876 Wilshire Blvd.\n\nBeverly Hills\, CA 90210 CATEGORIES:Conference LOCATION:Beverly Hilton Hotel\, 9876 Wilshire Blvd.\, Beverly Hills\, CA\, 90210\, United States X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=9876 Wilshire Blvd.\, Bever ly Hills\, CA\, 90210\, United States;X-APPLE-RADIUS=100;X-TITLE=Beverly H ilton Hotel:geo:0,0 END:VEVENT BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:DAYLIGHT DTSTART:20180311T030000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE END:VCALENDAR